Affinity-Driven Covalent Modulator of the Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Cascade. 2018

Jeffy Chern, and Chun-Ping Lu, and Zhanxiong Fang, and Ching-Ming Chang, and Kuo-Feng Hua, and Yi-Ting Chen, and Cheng Yang Ng, and Yi-Lin Sophia Chen, and Yulin Lam, and Shih-Hsiung Wu
Institute of Biological Chemistry, Academia Sinica, Taiwan.

Traditional medicines provide a fertile ground to explore potent lead compounds, yet their transformation into modern drugs is fraught with challenges in deciphering the target that is mechanistically valid for its biological activity. Herein we reveal that (Z)-(+)-isochaihulactone (1) exhibited significant inhibition against multiple-drug-resistant (MDR) cancer cell lines and mice xenografts. NMR spectroscopy showed that 1 resisted an off-target thiolate, thus indicating that 1 was a target covalent inhibitor (TCI). By identifying the pharmacophore of 1 (α,β-unsaturated moiety), a probe derived from 1 was designed and synthesized for TCI-oriented activity-based proteome profiling. By MS/MS and computer-guided molecular biology approaches, an affinity-driven Michael addition of the noncatalytic C247 residue of GAPDH was found to control the "ON/OFF" switch of apoptosis through non-canonically nuclear GAPDH translocation, which bypasses the common apoptosis-resistant route of MDR cancers.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D005987 Glyceraldehyde-3-Phosphate Dehydrogenases Enzymes that catalyze the dehydrogenation of GLYCERALDEHYDE 3-PHOSPHATE. Several types of glyceraldehyde-3-phosphate-dehydrogenase exist including phosphorylating and non-phosphorylating varieties and ones that transfer hydrogen to NADP and ones that transfer hydrogen to NAD. GAPD,Glyceraldehyde-3-Phosphate Dehydrogenase,Glyceraldehydephosphate Dehydrogenase,Phosphoglyceraldehyde Dehydrogenase,Triosephosphate Dehydrogenase,Dehydrogenase, Glyceraldehyde-3-Phosphate,Dehydrogenase, Glyceraldehydephosphate,Dehydrogenase, Phosphoglyceraldehyde,Dehydrogenase, Triosephosphate,Dehydrogenases, Glyceraldehyde-3-Phosphate,Glyceraldehyde 3 Phosphate Dehydrogenase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D015107 4-Butyrolactone One of the FURANS with a carbonyl thereby forming a cyclic lactone. It is an endogenous compound made from gamma-aminobutyrate and is the precursor of gamma-hydroxybutyrate. It is also used as a pharmacological agent and solvent. 1,4-Butanolide,4-Hydroxybutyric Acid Lactone,Furanone, tetrahydro-2-,gamma-Butyrolactone,Dihydro-2(3H)-furanone,1,4 Butanolide,4 Butyrolactone,4 Hydroxybutyric Acid Lactone,Furanone, tetrahydro 2,Lactone, 4-Hydroxybutyric Acid,gamma Butyrolactone
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Jeffy Chern, and Chun-Ping Lu, and Zhanxiong Fang, and Ching-Ming Chang, and Kuo-Feng Hua, and Yi-Ting Chen, and Cheng Yang Ng, and Yi-Lin Sophia Chen, and Yulin Lam, and Shih-Hsiung Wu
December 2014, Pathologie-biologie,
Jeffy Chern, and Chun-Ping Lu, and Zhanxiong Fang, and Ching-Ming Chang, and Kuo-Feng Hua, and Yi-Ting Chen, and Cheng Yang Ng, and Yi-Lin Sophia Chen, and Yulin Lam, and Shih-Hsiung Wu
October 2021, Biochimica et biophysica acta. Molecular basis of disease,
Jeffy Chern, and Chun-Ping Lu, and Zhanxiong Fang, and Ching-Ming Chang, and Kuo-Feng Hua, and Yi-Ting Chen, and Cheng Yang Ng, and Yi-Lin Sophia Chen, and Yulin Lam, and Shih-Hsiung Wu
June 2017, Biochemistry. Biokhimiia,
Jeffy Chern, and Chun-Ping Lu, and Zhanxiong Fang, and Ching-Ming Chang, and Kuo-Feng Hua, and Yi-Ting Chen, and Cheng Yang Ng, and Yi-Lin Sophia Chen, and Yulin Lam, and Shih-Hsiung Wu
December 2014, Biochemical Society transactions,
Jeffy Chern, and Chun-Ping Lu, and Zhanxiong Fang, and Ching-Ming Chang, and Kuo-Feng Hua, and Yi-Ting Chen, and Cheng Yang Ng, and Yi-Lin Sophia Chen, and Yulin Lam, and Shih-Hsiung Wu
December 2013, Chemico-biological interactions,
Jeffy Chern, and Chun-Ping Lu, and Zhanxiong Fang, and Ching-Ming Chang, and Kuo-Feng Hua, and Yi-Ting Chen, and Cheng Yang Ng, and Yi-Lin Sophia Chen, and Yulin Lam, and Shih-Hsiung Wu
April 2020, Cancers,
Jeffy Chern, and Chun-Ping Lu, and Zhanxiong Fang, and Ching-Ming Chang, and Kuo-Feng Hua, and Yi-Ting Chen, and Cheng Yang Ng, and Yi-Lin Sophia Chen, and Yulin Lam, and Shih-Hsiung Wu
August 2010, Toxicological sciences : an official journal of the Society of Toxicology,
Jeffy Chern, and Chun-Ping Lu, and Zhanxiong Fang, and Ching-Ming Chang, and Kuo-Feng Hua, and Yi-Ting Chen, and Cheng Yang Ng, and Yi-Lin Sophia Chen, and Yulin Lam, and Shih-Hsiung Wu
November 2018, BioFactors (Oxford, England),
Jeffy Chern, and Chun-Ping Lu, and Zhanxiong Fang, and Ching-Ming Chang, and Kuo-Feng Hua, and Yi-Ting Chen, and Cheng Yang Ng, and Yi-Lin Sophia Chen, and Yulin Lam, and Shih-Hsiung Wu
December 2011, Biochimica et biophysica acta,
Jeffy Chern, and Chun-Ping Lu, and Zhanxiong Fang, and Ching-Ming Chang, and Kuo-Feng Hua, and Yi-Ting Chen, and Cheng Yang Ng, and Yi-Lin Sophia Chen, and Yulin Lam, and Shih-Hsiung Wu
November 2013, Nitric oxide : biology and chemistry,
Copied contents to your clipboard!